Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # Hoffmann-La Roche
  • # Johnson&Johnson
  • # DNA
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Positive Outcomes From the Initial Prenatal Therapy for Spinal Muscular Atrophy

20 February 2025

Research: Pain in the brain can be relieved by focused ultrasound

7 February 2024

Studies have revealed the stiffening of a cell’s environment propels cancer progression

22 December 2024

AstraZeneca Secures EU’s Approval for Fixed-Duration Calquence-Based Regimens in First-Line Chronic Lymphocytic Leukemia (CLL)

7 June 2025

Roche’s Evrysdi® Tablet Receives European Commission Approval, Enhancing Treatment Flexibility for Spinal Muscular Atrophy Patients

4 June 2025

Diagnosis of bipolar disorder is very simple using a blood test to identify biomarkers; A study at the University of Cambridge

27 October 2023

Researchers discovered a new Gene Therapy for muscular dystrophy

18 July 2024

Pfizer Announces Development Discontinuation of Danuglipron an Oral GLP-1 Receptor Agonist

14 April 2025

New effective drug against flesh-eating bacteria

5 August 2024

Human Genome Project (HGP) – Overview

16 April 2023

AstraZeneca Released Satisfactory Results of 24 Weeks CALYPSO Phase III Trial for Eneboparatide

17 March 2025

Treatment of lung cancer with a type of allergy medicine – Research

8 December 2023

mRNA Therapies

Researchers developed lipid nanoparticles for netter mRNA therapies
Healthcare & Pharmaceuticals Research

Researchers developed lipid nanoparticles for netter mRNA therapies

Editor's Desk 23 November 2024

It is anticipated that this novel approach to creating ionizable lipids will have significant effects on mRNA-based vaccines and treatments, which are positioned to address a variety of illnesses, including infectious diseases and genetic abnormalities.

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Cytiva Hiring a Quality Control Technician in Cardiff, United Kingdom
  • PhD Position in Dialysis Therapy – University of Twente, Netherlands
  • Eli Lilly and Company Hiring a Analytical Technical Steward-Peptides in Hyderabad, India – June, 2025
  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
SciRealityPress BiotechReality

A SciRealityPress Associate

DMCA.com Protection Status

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status